Overview #
Hypernatremia: serum sodium >145mmol/L, severe >160mmol/L (1)
- Indicates hypertonicity and decreased cell volume, all patients have high serum osmolality (1)
- Inadequate water intake is an important cause in the very young and very old (2)
Key Points
- Major causes: dehydration, thiazide diuretics
- Maximum reduction 0.5mmol/L per hour
- Maximum reduction 10mmol/L in 24 hours
Triage #
Attend within hours
- Unless impaired mental status
Causes #
Major cause of hypernatremia = water depletion = dehydration
Unreplaced water loss (which requires an impairment in either thirst or access to water) (3)
- Inadequate water intake
- Insensible and sweat losses
- increased by fever, exercise, exposure to high temperatures
- Gastrointestinal losses
- Osmotic diarrhoea NOT secretory diarrhoea
- Burns
- Central or nephrogenic diabetes insipidus
- Reduced anti-diuretic hormone (ADH) release or renal resistance to ADH
- Drugs
- Thiazide and related diuretics (indapamide, hydrochlorothiazide, chlortalidone)
- Osmotic diuresis
Increased urine output with low Na/K concentration (< plasma concentration)
- Glucose in uncontrolled diabetes mellitus
- Urea in high-protein tube feedings or recovery from azotaemia
- Mannitol
- Hypothalamic lesions impairing thirst or osmoreceptor function
- Primary hypodipsia
- Reset osmostat in mineralocorticoid excess
Water loss into cells (transient) (3)
- Severe exercise
- Rhabdomyolysis (1)
- Seizures
Sodium overload (3)
- Intake or administration of hypertonic sodium solutions
- Enemas
- ICU-acquired positive solute balance
Clinical Features #
Signs and symptoms (1, 3)
- Orthostatic hypotension
- Oliguria
- Excess thirst
- Lethargy
- Weakness
- Confusion, irritability
- Seizures
- Coma
Neurological symptoms due to depletion of intracerebral fluid (2)
History
- Fluid intake (low)
- Altered mental status
- Access to water
- Physical restraints
- Unable to communicate need for water
- Fluid losses
- Diuretics
- Diarrhoea, vomiting
- Diabetes insipidus
Examination
- Fluid assessment
Investigations #
Initial Investigations | Significance |
VBG | Quick assessment of electrolytes |
UEC | Accurate serum sodium level |
FBE | HaematocritRaised in hypovolaemia |
Urine osmolality (if unclear cause) | <300mosmol/kgLikely diabetes insipidus300-600mosmol/kgLikely osmotic diuresis or diabetes insipidus>600mosmol/kgLikely extra renal water losses |
Further Investigations | Significance |
Urine Na | Distinguish between GIT/renal/insensible loss/Na overload<25mEq/LWater loss and volume depletion>100mEq/LNa ingestion, hypertonic saline |
Plasma osmolality | Paired with urine osmolality to determine response and distinguish water loss vs partial diabetes insipidus |
CT/MRI Brain | Discussion with senior staff necessary |
Classification #
- Acute (uncommon)
- Hypernatremia for <48 hours
- Diabetes insipidus or salt poisoning
- Chronic (majority of patients)
- Hypernatremia for >48 hours
- This will impact how quickly you can reduce serum Na levels ???? risk of cerebral oedema
Management #
Escalate to senior team member: registrar
Acute Hypernatremia
Aim: replace water deficit in 24 hours (2, 4)
- Correct cause and replace fluid deficit
- Oral fluid replacement^ (if able) OR
- IV glucose 5%
- Rate: 3-6mL/kg/hr
- Replace ongoing free water losses
- Monitor serum Na 1-2 hourly until <145mmol/L
If over/undercorrection noted escalate to senior team members
- Osmotic demyelination is rare in acute hypernatremia (as no time for cerebral adaptation) (4)
Monitor for hyperglycaemia
Chronic Hypernatremia
Aim: lower serum Na by 10mEq/L in 24 hours (2, 4)
- Correct cause and replace fluid deficit
- Oral fluid replacement^ (if able) OR
- IV glucose 5% (see below for rate calculation)
- Replace ongoing free water losses
- Monitor serum Na 4-6 hourly
- Once target correction rate reached, monitor 12-24 hourly
If over/undercorrection noted escalate to senior team members
- Undercorrection
- Increase rate of glucose infusion
- Overcorrection
- May require hypotonic 0.45% normal saline as even slow rates of glucose may be too much (4, 6)
- CALL OUT BOX:
- 0.45% normal saline sodium content is 154 mmol/L
- If serum sodium is >154 mmol/L, administering normal saline will still lower the level, slower than dextrose
Monitor for hyperglycaemia and any change in neurological signs or symptoms (escalate if noticed)
Diabetes Insipidus: TO BE ESCALATED TO ENDOCRINOLOGY FOR EXPERT ADVICE
- Desmopressin* (1, 3, 4, 5)
- Regulation of water intake (If impaired thirst sensation)
References #
- Papadakis, MA, McPhee SJ, Rabow MW. Current Medical Diagnosis & Treatment 2021. 60th ed. New York: McGraw-Hill Education; 2021.
- eTG Complete [Internet]. Melbourne (Vic): Therapeutic Guidelines Ltd; 2014. Hypernatremia [updated 2021 Mar; cited 2021 Aug 25]. Available from: https://tgldcdp.tg.org.au.acs.hcn.com.au/viewTopic?topicfile=electrolyte-abnormalities&guidelineName=Other#toc_d1e632
- Sterns RH. Etiology and evaluation of hypernatremia in adults. In: Emmett M, Forman JP, editors. UpToDate. [Internet]. UpToDate; 2019 [updated 2019 Sep 23; cited 2021 Aug 25]. Available from: https://www.uptodate.com/contents/etiology-and-evaluation-of-hypernatremia-in-adults?search=hypernatremia&source=search_result&selectedTitle=2~150&usage_type=default&display_rank=2
- Sterns RH, Hoorn EJ. Treatment of hypernatremia in adults. In: Emmett M, Forman JP, editors. UpToDate. [Internet]. UpToDate; 2020 [updated 2020 Jul 23; cited 2021 Aug 25]. Available from: https://www.uptodate.com/contents/treatment-of-hypernatremia-in-adults?search=hypernatremia&source=search_result&selectedTitle=1~150&usage_type=default&display_rank=1
- eTG Complete [Internet]. Melbourne (Vic): Therapeutic Guidelines Ltd; 2019. Arginine vasopressin replacement and diabetes insipidus in hypopituitarism [updated 2020 Dec; cited 2021 Aug 25]. Available from: https://tgldcdp.tg.org.au.acs.hcn.com.au/viewTopic?topicfile=hypopituitarism§ionId=bmg2-c13-s7#bmg2-c13-s7
- Kim SW. Hypernatemia: successful treatment. Electrolyte Blood Press. 2006 Nov;4(2):66-71. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3894528/#:~:text=Patients%20should%20be%20given%20intravenous,unable%20to%20tolerate%20oral%20water
Contributors
Reviewing Consultant/Senior Registrar
Dr Jessica Reece
Dr Catherine Seymour